Single doses of SAR441255 up to 150 g were well tolerated and the most frequent treatment-emergent adverse events were gastrointestinal disorders, as is typical with these compounds
However, the same compounds, marketed under different names (Wegovy and Zepbound, respectively), are approved for weight loss in those with a body mass index (BMI) greater than 30
Current research on the link between Semaglutide and hot flashes is still evolving
The two groups were matched for factors such as: age body mass index (BMI) other health conditions prior migraine treatments The GLP-1 medications included in the study were: liraglutide (Saxenda, Victoza) semaglutide (Ozempic, Wegovy) dulaglutide (Trulicity) exenatide (Byetta, Bydureon) lixisenatide (Adlyxin) albiglutide (Tanzeum, Eperzan) The researchers found that 23.7% of people using GLP-1 drugs visited the emergency room in the following year
Research consistently shows that adequate protein (0.7-1.0 grams per pound of lean body mass) helps preserve muscle during rapid weight loss